High MIG-6 expression promotes tumor proliferation and metastasis of gastric cancer
Wenqiu Zhao, Tao Jin, Yun Liu, Shihe Shao, Feilun Cui · Journal of Cancer · 2025
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2025
Abstract
Background: Mitogen-inducible gene-6 (MIG-6) is a feedback inhibitor that targets activated epidermal growth factor receptor (EGFR) and suppresses tumor growth fueled by constitutively activated EGFR.Nevertheless, the action mechanism of MIG-6 in gastric cancer (GC) remains to be elucidated.Methods: Western blotting, fluorescence quantitative PCR, and immunohistochemistry were performed to detect the expression of MIG-6 in GC cell lines and tissues.Public databases were used to analyze MIG-6 in patients with GC.Furthermore, the GC cell lines were selected for the knockdown and overexpression of MIG-6.Results: Bioinformatics and histological analyses showed that MIG-6 was elevated in human GC tissues and cells.The Kaplan-Meier plotter showed that patients with elevated MIG-6 expression had significantly shorter survival.Furthermore, small interference RNA-mediated reduction of MIG-6 expression decreased EGFR/AKT signaling, as well as the proliferation and metastasis of human GC cells in vitro, whereas its overexpression increased these actions.Also, MIG-6 overexpression promoted the epithelial-mesenchymal transition of GC cells as well as the expression of the migration-associated protein matrix metalloproteinase-9 in vitro.Conclusion: These results suggest that MIG-6 can serve as a new prognostic biomarker or potential therapeutic target for the identification of patients with poor survival.
Open the resolved locator · 10.7150/jca.98431
Metadata licence: OpenAlex metadata (CC0)